Page 3 - ஆராய்ச்சி ஆரம்ப வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novo Nordisk s net profit increased by 8% in 2020
Novo Nordisk A/S
Financial report for the period 1 January 2020 to 31 December 2020
Sales increased by 4% in Danish kroner and by 7% at CER to DKK 126.9 billion. Sales in International Operations increased by 7% in Danish kroner (10% at CER), and sales in North America Operations increased by 1% in Danish kroner (3% at CER). Sales growth was negatively impacted by COVID-19, driven by fewer patients initiating treatment.
Sales within Diabetes and Obesity care increased by 5% to DKK 108.0 billion (8% at CER), driven by GLP-1 growth of 26% in Danish kroner (29% at CER) reflecting the uptake of Ozempic
® and Rybelsus
®. Biopharm sales decreased by 1% in Danish kroner (increased by 1% at CER). ....

United States , Daniel Muusmann Bohsen , Lars Fruergaard , Mette Kruse Danielsen , Martin Holst Lange , Krogsgaard Thomsen , Valdemar Borum Svarrer , Marcus Schindler , Michael Bachner , Novo Nordisk , York Stock Exchange , International Operations , Research Early Development , Sales In International Operations , North America Operations , Mads Krogsgaard Thomsen , Early Development , Annual General Meeting , Strategic Aspirations , Nasdaq Copenhagen , New York Stock Exchange , Annual General , Due Berg , ஒன்றுபட்டது மாநிலங்களில் , மெத்தே க்ரூஸ் டேனியல்சன் , மார்டின் ஹோல்ஸ்ட் லாங்கே ,